Aktive Positionen von Pan Zheng
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
OncoImmune, Inc.
 OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Gründer | 01.01.2000 | - |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2000 | - | |
| Direktor/Vorstandsmitglied | 01.01.2000 | - | |
| Oncoc4, Inc. | Gründer | - | - |
| Corporate Officer/Principal | - | - |
Karriereverlauf von Pan Zheng
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Founder | 2 |
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
OncoImmune, Inc.
OncoImmune, Inc. Pharmaceuticals: MajorHealth Technology OncoImmune, Inc. engages in the research and development of biopharmaceuticals for the treatment of cancer and autoimmune diseases. It offers CD24Fc, a recombinant fusion protein that targets a novel immune pathway checkpoint; Sialidase Inhibitors, ONC-392, and Echinomycin. The company was founded by Kun-Liang Guan, Ming You, Yang Liu, and Pan Zheng in 2000 and is headquartered in Rockville, MD. | Health Technology |
| Oncoc4, Inc. |
